Catherine Bollard, MD, MBChB

6:05

Drs. Catherine Bollard and Sagar Lonial discuss advances and open research questions in cell-based therapy for hematologic malignancies, including the need to improve on efficacy while mitigating, and better understanding the underlying mechanisms of, CAR T cell therapy toxicity particularly neurotoxocity